论文部分内容阅读
美国糖尿病学会(ADA)2017年1月发布了“2017年糖尿病医学诊疗标准”。2017ADA标准内容上亦有了较多更新,甚至在某些方面颠覆了传统观念,与国内的指南或共识也存在一定差异。荫低血糖:精细分3级,不再一个数值一刀切新标准依然强调血糖自我监测和糖化血红蛋白监测的重要性,在某些情况可以联合动态血糖监测。低血糖内容的更新,是2017年ADA标准的一大亮点。根据国际低血糖研究组建议,低血糖分为低血糖
American Diabetes Association (ADA) January 2017 released the “2017 diabetes medical treatment standards.” There are also more updates on the content of the 2017ADA standard, and even subvert the traditional concepts in some aspects. There are also some differences with domestic guidelines or consensus. Dark hypoglycemia: fine level 3, no longer a single value The new standard still emphasizes the importance of self-monitoring of blood glucose and glycosylated hemoglobin monitoring, in some cases can be combined with dynamic glucose monitoring. The update of the hypoglycemic content is a major highlight of the 2017 ADA standard. According to the recommendations of the International Low Glucose Study Group, hypoglycemia is divided into hypoglycemia